Host Cell Metabolism Goes Viral: Unveiling How HEV Hijacks Your Cells

Hepatitis E virus (HEV) is a major cause of acute and chronic hepatitis, with severity depending on the viral genotype. HEV-1 infection can be particularly severe during pregnancy, whereas HEV-3 is typically mild, except in elderly or immunocompromised individuals.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

SpringerLink
SpringerLink SpringerLink

Mitochondrial and lipid metabolism rewiring during HEV infection - Cellular and Molecular Life Sciences

Hepatitis E virus (HEV), a leading cause of acute and chronic viral hepatitis, poses a persistent global health challenge. A deeper mechanistic understanding of virus–host interactions is critical for identifying therapeutic targets to mitigate HEV-associated disease. In this study, we employ a systems biology framework to comprehensively map metabolic and bioenergetic alterations induced by HEV genotypes 1 and 3 in HepG2/C3a-MAVS-KD cells, a robust model of HEV infection, enabling reliable assessment of virus- and host-driven cellular changes. Our analyses reveal extensive remodelling of host metabolism, including reprogramming of the tricarboxylic acid (TCA) cycle, mitochondrial oxidative phosphorylation (OXPHOS), fatty acid metabolism, and β-oxidation—pathways that collectively sustain the energetic and biosynthetic demands of viral infection. HEV infection also reshapes the cellular lipidome, increasing levels of long-chain neutral lipids and lipid droplet abundance, alongside elevated levels of pro-inflammatory oxylipins. Functional metabolic assays demonstrate a reliance on lipid-fuelled OXPHOS rather than glycolysis for efficient HEV infection. These findings uncover critical host metabolic dependencies exploited by HEV and offer a conceptual framework for targeting metabolic hubs as a therapeutic strategy against HEV infection. Author Summary: Viruses are obligate intracellular pathogens that reprogramme host cellular machinery to their advantage. Yet, the extent to which Hepatitis E virus (HEV) infection orchestrates metabolic reprogramming, and the implications of these changes for viral fitness, remain poorly defined. By integrating large-scale proteomics with lipid metabolic profiling, we delineate molecular strategies through which HEV subverts host lipid metabolism and mitochondrial function. Our findings provide mechanistic insight into how HEV infection modulates host metabolic pathways to its advantage, highlighting potential targets for therapeutic intervention. Graphical Abstract

Our latest study (Glaziou et al., 2026, Mol Cell Life Sci) reveals that HEV hijacks host cell metabolism to fuel its replication:

  • TCA cycle, mitochondrial oxidative phosphorylation (OXPHOS), fatty acid metabolism, and β-oxidation, are extensively rewired.
  • Lipid storage organelles expand, long-chain neutral lipids accumulate, and pro-inflammatory oxylipins surge.
  • HEV relies on lipid-fuelled OXPHOS rather than glycolysis.
  • Distinct metabolic programs for HEV-1 versus HEV-3, aligning with their differential pathogenicity.

These findings highlight critical host metabolic vulnerabilities exploited by HEV and provide a roadmap for targeting metabolic hubs as therapy.

Interestingly, while our previous work in placental models (Gouilly et al., 2018, Nat Commun) showed HEV-1 triggers inflammatory damage at the maternal-fetal interface, the placenta is a highly active metabolic organ, and how HEV reshapes its metabolism remains an exciting question for future studies. 

Takeaway: HEV doesn’t just infect—it reprograms, fuels, and manipulates host metabolism to thrive. Understanding these strategies could point to novel therapeutic interventions.

Key metabolic and signalling pathways remodelled in hepatocytes upon HEV infection.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Virology
Life Sciences > Biological Sciences > Microbiology > Virology
Hepatitis
Life Sciences > Biological Sciences > Microbiology > Medical Microbiology > Infectious Diseases > Hepatitis
Metabolism
Physical Sciences > Chemistry > Biological Chemistry > Metabolism
Mitochondria
Life Sciences > Biological Sciences > Cell Biology > Organelles > Mitochondria

Related Collections

With Collections, you can get published faster and increase your visibility.

TME-Driven Metastasis and Adaptive Phenotypes

The tumor microenvironment (TME) is a dynamic and multifaceted ecosystem that shapes nearly every aspect of cancer progression, from early tumor evolution to metastatic spread and therapeutic response. Dynamic interactions between tumor cells, stromal components, immune infiltrates, and extracellular matrix structures not only cell migration and invasion but also broader adaptive phenotypes such as metabolic rewiring, immune escape, therapy resistance, and phenotypic plasticity. Recent advances in single-cell omics, live-cell imaging, spatial transcriptomics, and functional modeling systems (e.g. organoids, organ-on-chip) have illuminated how bidirectional communication within the TME governs these behaviors.

This collection invites cutting-edge research and comprehensive reviews that dissect the cellular and molecular mechanisms by which the TME drives tumor dissemination and adaptive cancer cell states. We welcome interdisciplinary contributions spanning molecular oncology, immunology, systems biology, and bioengineering, with an emphasis on translational insights that inform therapeutic targeting of TME-driven and immune-regulatory pathways in cancer.

Topics of Interest

  • Molecular mechanisms of tumor cell migration and invasion
  • Crosstalk between tumor cells, fibroblasts, and immune cells in the TME
  • Role of cytokines, chemokines, and extracellular vesicles in cell migration
  • Immunomodulatory effects of the TME on metastatic potential
  • ECM remodeling and mechanotransduction in cancer cell motility
  • Computational and imaging approaches to study cell migration in vivo
  • Targeting migration-associated signaling (e.g., EMT, integrins, PI3K, Rho GTPases)
  • Interplay between immune checkpoint pathways and migratory signaling
  • Tumor-derived exosomes and their role in pre-metastatic niche formation
  • Translational strategies for inhibiting TME-driven metastasis

Publishing Model: Open Access

Deadline: Dec 27, 2026